SCHEMBL435610

SCHEMBL435610

CCCCC(C(=O)O)C1CCCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.43
CA2 P00918 1/20 0.42
MAPK1 P28482 1/20 0.42
SIGMAR1 Q99720 1/20 0.41
EPHX1 P07099 7/20 0.40
MMP1 P03956 1/20 0.40
MMP7 P09237 1/20 0.40
MMP12 P39900 1/20 0.40
ECE1 P42892 1/20 0.40
MMP13 P45452 1/20 0.40
LCK P06239 1/20 0.40
PPARD Q03181 1/20 0.40
ZDHHC20 Q5W0Z9 1/20 0.40
ZDHHC2 Q9UIJ5 1/20 0.40
TSHR P16473 1/20 0.39
EPHX2 P34913 1/20 0.39
METAP1 P53582 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1527354 0.98 CA2 (0.44) CYP2C9CYP2C19HIF1ASMN1; SMN2CA2
SCHEMBL407615 0.98 CA2 (0.44) CYP2C9CYP2C19HIF1ASMN1; SMN2CA2
SCHEMBL1032475 0.95 LCK (0.47) CYP2C9CYP2C19HIF1ASMN1; SMN2EPHX1
SCHEMBL9861922 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK
SCHEMBL10494941 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK
SCHEMBL28418904 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK
SCHEMBL8736617 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK
SCHEMBL2555276 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK
SCHEMBL181506 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK
SCHEMBL3272020 0.93 LCK (0.50) CYP2C9CYP2C19HIF1AEPHX1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 901 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4504813-B1 SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION H K WENTWORTH LTD (GB) 2026-02-11 EP claimed
US-20250206983-A1 SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION H K WENTWORTH LTD (GB) 2025-06-26 US claimed
EP-4504813-A1 SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION H. K. Wentworth Limited (GB) 2025-02-12 EP claimed
WO-2023193952-A1 SINGLE COMPONENT UV CURABLE CONFORMAL COATING WITH MOISTURE SECONDARY CURE FUNCTION H. K. WENTWORTH LIMITED (GB) 2023-10-12 WO claimed
EP-3383359-B1 A FRAGRANCE COMPOSITION SYMRISE AG (DE) 2022-08-03 EP claimed
US-20220165954-A1 FORMULATION CONTAINING A CROSSLINKABLE POLYMER MERCK PATENT GMBH (DE) 2022-05-26 US claimed
EP-3956379-A1 FORMULATION CONTAINING A CROSSLINKABLE POLYMER Merck Patent GmbH (DE) 2022-02-23 EP claimed
WO-2020212295-A1 FORMULATION CONTAINING A CROSSLINKABLE POLYMER MERCK PATENT GMBH (DE) 2020-10-22 WO claimed
US-10016749-B2 Catalyst composition for hydrogenation and method for hydrogenation using the same ASAHI KASEI CHEMICALS CORPORATION (JP) 2018-07-10 US claimed
EP-2204156-B1 Fragrance composition for core shell microcapsules TAKASAGO PERFUMERY CO LTD (JP) 2017-02-01 EP claimed
WO-2011101181-A1 PERFUME COMPOSITIONS HENKEL AG & CO. KGAA (DE) 2011-08-25 WO claimed
EP-2211829-A1 IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS Henkel AG & Co. KGaA (DE) 2010-08-04 EP claimed
WO-2009059858-A1 IMPROVEMENT OF THE FRAGRANCE EFFECT OF PERFUME ESTERS HENKEL AG & CO. KGAA (DE) 2009-05-14 WO claimed
US-20080234173-A1 PRESERVATIVE COMPOSITIONS TAKASAGO INTERNATIONAL CORPORATION (JP) 2008-09-25 US claimed
EP-1948773-A1 FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS Henkel AG & Co. KGaA (DE) 2008-07-30 EP claimed
WO-2007054177-A1 FRAGRANT CONSUMER PRODUCTS COMPRISING OXIDIZING AGENTS HENKEL AG & CO. KGAA (DE) 2007-05-18 WO claimed
WO-2007042410-A1 DEODORIZING CLEANSING PREPARATION BEIERSDORF AG (DE) 2007-04-19 WO claimed
WO-2006105842-A1 SYNERGISTS FOR BOOSTING THE ACTION OF REPELLENTS MERCK PATENT GMBH (DE) 2006-10-12 WO claimed
WO-2026104430-A1 USE OF SILICON COMPOUNDS IN AN ELECTRONIC DEVICE MERCK PATENT GMBH (DE) 2026-05-21 WO disclosed
US-3948814-A Acetaldehyde ethyl linalyl acetal perfume compositions NAARDEN INTERNATIONAL, N.V. (NL) 1976-04-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10016749-B2 Catalyst composition for hydrogenation and method for hydrogenation using the same H1-0, H1-2, HVCN1 CYP2C9 1823/4885CYP2C19 2138/4885HIF1A 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.